| Differential Activation and Modulation of the Glucagon-like Peptide-1 Receptor by Small Molecule Ligands. | |
| | |
MedLine Citation:
|
PMID: 23348499 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
The glucagon-like peptide-1 receptor (GLP-1R) is a major therapeutic target for the treatment of type 2 diabetes due to its role in glucose homeostasis. Despite the availability of peptide based GLP-1R drugs for treatment of this disease, there is great interest in developing small molecules that can be administered orally. The GLP-1R system is complex, with multiple endogenous and clinically used peptide ligands that exhibit different signalling biases at this receptor. This study revealed that small molecule ligands acting at this receptor are differentially biased to peptide ligands and also from each other with respect to the signalling pathways that they activate. Furthermore, allosteric, small molecule ligands were able to induce bias in signalling mediated by orthosteric ligands. This was dependent on both the orthosteric and allosteric ligand as no two allosteric-orthosteric ligand pairs could induce the same signalling profile. We highlight the need to profile compounds across multiple signalling pathways and in combination with multiple orthosteric ligands in systems such as the GLP-1R where more than one endogenous ligand exists. In the context of pleiotropical coupling of receptors and the interplay of multiple pathways leading to physiological responses, profiling of small molecules in this manner may lead to a better understanding of the physiological consequences of biased signalling at this receptor. This could enable the design and development of improved therapeutics that have the ability to fine-tune receptor signalling leading to beneficial therapeutic outcomes while reducing side effect profiles. |
| | |
Authors:
|
Denise Wootten; Emilia E Savage; Francis S Willard; Ana B Bueno; Kyle W Sloop; Arthur Christopoulos; Patrick Sexton |
Related Documents
:
|
18404459 - The p2y(4) receptor forms homo-oligomeric complexes in several cns and pns neuronal cells. 8032599 - A nucleotide receptor that mobilizes ca2+ in the mouse submandibular salivary cell line... 8690069 - Molecular cloning and functional expression of a novel rat heart p2x purinoceptor. 17993619 - P2y receptor signaling regulates phenotype and ifn-alpha secretion of human plasmacytoi... 17394459 - Differential role of extracellular histidines in copper, zinc, magnesium and proton mod... 18295749 - Atp facilitates glutamatergic neurotransmission to cardiac vagal neurons in the nucleus... 11406289 - Cloning of the mouse 5-ht6 serotonin receptor and mutagenesis studies of the third cyto... 12729839 - Taurine reduces ammonia- and n-methyl-d-aspartate-induced accumulation of cyclic gmp an... 9060029 - Alpha 2-adrenergic receptor subtypes in rat dorsal root and superior cervical ganglion ... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2013-1-24 |
Journal Detail:
|
Title: Molecular pharmacology Volume: - ISSN: 1521-0111 ISO Abbreviation: Mol. Pharmacol. Publication Date: 2013 Jan |
Date Detail:
|
Created Date: 2013-1-25 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0035623 Medline TA: Mol Pharmacol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
1 Monash University; |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Ionotropic Glutamate Receptors: Regulation by G-protein Coupled Receptors.
Next Document: A Novel Metabotropic Glutamate Receptor 5 Positive Allosteric Modulator Acts at a Unique Site and Co...